Patent ID: 7902170

Claim:
A method for the treatment of a condition caused by human influenza virus, said method comprising administering a pharmaceutically effective amount of a substance to a patient in need thereof, wherein said substance comprises at least one oligosaccharide chain, said oligosaccharide chain comprising a terminal NeuNAcα6 linked to (a) a branched polylactosamine type structure consisting of at least three lactosamine residues glycosidically linked to each other, wherein: the structure optionally contains one or more additional NeuNAcα6 residues at a terminal position in a branch; and/or (b) a branched structure consisting of two lactosamine and one lactose residue glycosidically linked to each other, wherein: the structure optionally contains one or more additional NeuNAcα6 residues at a terminal position of the branch, and wherein said substance contains two NeuNAcα6 residues in a branched structure.